PLUN Stock Overview
A medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ProstaLund AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 2.04 |
| 52 Week Low | SEK 0.20 |
| Beta | 0.55 |
| 11 Month Change | -2.43% |
| 3 Month Change | -32.68% |
| 1 Year Change | -86.57% |
| 33 Year Change | -94.73% |
| 5 Year Change | -92.70% |
| Change since IPO | -98.49% |
Recent News & Updates
Shareholder Returns
| PLUN | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.4% | -2.2% | 0.1% |
| 1Y | -86.6% | -6.0% | 11.8% |
Return vs Industry: PLUN underperformed the Swedish Medical Equipment industry which returned -6% over the past year.
Return vs Market: PLUN underperformed the Swedish Market which returned 11.8% over the past year.
Price Volatility
| PLUN volatility | |
|---|---|
| PLUN Average Weekly Movement | 13.3% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: PLUN's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PLUN's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 9 | Anders Kristensson | prostalund.se |
ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra.
ProstaLund AB (publ) Fundamentals Summary
| PLUN fundamental statistics | |
|---|---|
| Market cap | SEK 29.65m |
| Earnings (TTM) | -SEK 19.94m |
| Revenue (TTM) | SEK 16.34m |
1.8x
P/S Ratio-1.5x
P/E RatioIs PLUN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLUN income statement (TTM) | |
|---|---|
| Revenue | SEK 16.34m |
| Cost of Revenue | SEK 4.86m |
| Gross Profit | SEK 11.48m |
| Other Expenses | SEK 31.42m |
| Earnings | -SEK 19.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 70.29% |
| Net Profit Margin | -122.04% |
| Debt/Equity Ratio | 1.8% |
How did PLUN perform over the long term?
See historical performance and comparison